{"id":254908,"date":"2025-08-06T11:31:36","date_gmt":"2025-08-06T09:31:36","guid":{"rendered":"https:\/\/health.saypro.online\/index.php\/2025\/08\/06\/saypro-neonatal-jaundice-screening-3\/"},"modified":"2025-08-13T11:31:12","modified_gmt":"2025-08-13T09:31:12","slug":"saypro-neonatal-jaundice-screening-3","status":"publish","type":"post","link":"https:\/\/health.neftaly.net\/index.php\/2025\/08\/06\/saypro-neonatal-jaundice-screening-3\/","title":{"rendered":"Neftaly Neonatal Jaundice Screening"},"content":{"rendered":"\n

Neftaly Neonatal Jaundice Screening<\/strong><\/h1>\n\n\n\n

1. Introduction<\/strong><\/h2>\n\n\n\n

Neonatal jaundice, characterized by yellowing of the skin and eyes due to elevated bilirubin levels, is a common condition affecting newborns. While often benign, severe jaundice can lead to serious complications like kernicterus if not detected and managed promptly.<\/p>\n\n\n\n

Neftaly\u2019s Neonatal Jaundice Screening guidelines aim to support early identification, monitoring, and timely intervention to prevent morbidity and mortality associated with neonatal jaundice.<\/p>\n\n\n\n

\n\n\n\n

2. Objectives<\/strong><\/h2>\n\n\n\n
    \n
  • Promote early recognition of jaundice in newborns<\/li>\n\n\n\n
  • Facilitate standardized screening protocols for timely diagnosis<\/li>\n\n\n\n
  • Guide appropriate management and referral pathways<\/li>\n\n\n\n
  • Reduce adverse outcomes from untreated hyperbilirubinemia<\/li>\n<\/ul>\n\n\n\n
    \n\n\n\n

    3. Risk Factors<\/strong><\/h2>\n\n\n\n
    Risk Factor<\/strong><\/th>Description<\/strong><\/th><\/tr><\/thead>
    Prematurity (less than 37 weeks)<\/td>Immature liver function affecting bilirubin metabolism<\/td><\/tr>
    Exclusive breastfeeding difficulties<\/td>Poor feeding can increase jaundice risk<\/td><\/tr>
    Hemolytic disease (e.g., blood group incompatibility)<\/td>Accelerated breakdown of red blood cells<\/td><\/tr>
    Family history of neonatal jaundice<\/td>Genetic predisposition<\/td><\/tr>
    Bruising or cephalohematoma at birth<\/td>Increased bilirubin production<\/td><\/tr>
    Infections<\/td>Can impair bilirubin clearance<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
    \n\n\n\n

    4. Screening Methods<\/strong><\/h2>\n\n\n\n

    4.1 Visual Assessment<\/strong><\/h3>\n\n\n\n
      \n
    • Inspect skin and sclera under natural light<\/li>\n\n\n\n
    • Use Kramer\u2019s scale to estimate jaundice progression from head to feet<\/li>\n\n\n\n
    • Note that visual assessment is less reliable in dark-skinned infants<\/li>\n<\/ul>\n\n\n\n

      4.2 Transcutaneous Bilirubinometry (TcB)<\/strong><\/h3>\n\n\n\n
        \n
      • Non-invasive device measuring bilirubin through the skin<\/li>\n\n\n\n
      • Useful for quick screening, especially in well-resourced settings<\/li>\n<\/ul>\n\n\n\n

        4.3 Serum Bilirubin Testing<\/strong><\/h3>\n\n\n\n
          \n
        • Confirmatory test measuring total serum bilirubin (TSB) levels<\/li>\n\n\n\n
        • Indicated when jaundice is visible or risk factors present<\/li>\n\n\n\n
        • Guides treatment decisions based on bilirubin thresholds<\/li>\n<\/ul>\n\n\n\n
          \n\n\n\n

          5. Timing of Screening<\/strong><\/h2>\n\n\n\n
            \n
          • First assessment within 24 hours of birth<\/li>\n\n\n\n
          • Repeat screening between 48 to 72 hours when physiological jaundice typically peaks<\/li>\n\n\n\n
          • More frequent monitoring for at-risk neonates or those with rising bilirubin<\/li>\n<\/ul>\n\n\n\n
            \n\n\n\n

            6. Management and Referral<\/strong><\/h2>\n\n\n\n
              \n
            • Mild jaundice:<\/strong> Encourage frequent feeding to promote bilirubin excretion<\/li>\n\n\n\n
            • Moderate to severe jaundice:<\/strong> Consider phototherapy based on TSB levels and clinical condition<\/li>\n\n\n\n
            • Critical levels or signs of encephalopathy:<\/strong> Urgent referral for intensive care and possible exchange transfusion<\/li>\n<\/ul>\n\n\n\n
              \n\n\n\n

              7. Prevention<\/strong><\/h2>\n\n\n\n
                \n
              • Promote early and exclusive breastfeeding<\/li>\n\n\n\n
              • Educate caregivers on recognizing jaundice and feeding difficulties<\/li>\n\n\n\n
              • Ensure clean delivery practices to reduce infection risk<\/li>\n\n\n\n
              • Monitor at-risk infants closely during the first week of life<\/li>\n<\/ul>\n\n\n\n
                \n\n\n\n

                8. Challenges and Solutions<\/strong><\/h2>\n\n\n\n
                Challenge<\/strong><\/th>Neftaly Strategy<\/strong><\/th><\/tr><\/thead>
                Limited access to bilirubin testing<\/td>Use clinical risk assessment and TcB devices where available<\/td><\/tr>
                Inconsistent follow-up<\/td>Establish community health worker follow-up visits<\/td><\/tr>
                Caregiver awareness gaps<\/td>Conduct education sessions on jaundice warning signs<\/td><\/tr>
                Resource constraints for phototherapy<\/td>Prioritize early detection and refer severe cases promptly<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
                \n\n\n\n

                9. Conclusion<\/strong><\/h2>\n\n\n\n

                Timely and effective neonatal jaundice screening is essential to prevent serious complications. Neftaly supports healthcare providers with practical guidelines and tools to enhance early detection and management of neonatal jaundice, improving newborn health outcomes.<\/p>\n\n\n\n

                \n\n\n\n

                For screening protocols, training materials, and technical support, contact Neftaly Maternal and Child Health Services.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

                Neftaly Neonatal Jaundice Screening 1. Introduction Neonatal jaundice, characterized by yellowing of the skin and eyes due to elevated bilirubin levels, is a common condition affecting newborns. While often benign, severe jaundice can lead to serious complications like kernicterus if not detected and managed promptly. Neftaly\u2019s Neonatal Jaundice Screening guidelines aim to support early identification, […]<\/p>\n","protected":false},"author":20,"featured_media":391881,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[29680,4,1899,1473],"class_list":["post-254908","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saypro-health-insights","tag-jaundice","tag-saypro","tag-neonatal","tag-screening"],"_links":{"self":[{"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/posts\/254908","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/comments?post=254908"}],"version-history":[{"count":0,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/posts\/254908\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/media\/391881"}],"wp:attachment":[{"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/media?parent=254908"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/categories?post=254908"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/tags?post=254908"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}